Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pathogenesis, Clinical Features, and Treatment of Patients with Myelin Oligodendrocyte Glycoprotein (MOG) Autoantibody-Associated Disorders Focusing on Optic Neuritis with Consideration of Autoantibody-Binding Sites: A Review.
Tanaka K, Kezuka T, Ishikawa H, Tanaka M, Sakimura K, Abe M, Kawamura M. Tanaka K, et al. Among authors: kezuka t. Int J Mol Sci. 2023 Aug 29;24(17):13368. doi: 10.3390/ijms241713368. Int J Mol Sci. 2023. PMID: 37686172 Free PMC article. Review.
Adenovirus-Associated Uveitis with Necrotizing Retinitis.
Sugita S, Usui Y, Watanabe H, Panto L, Iida M, Suginoshita K, Koyanagi KO, Nishida A, Kurimoto Y, Takahashi M, Shindo T, Nishioka H, Takano M, Kezuka T, Goto H, Kitaichi N. Sugita S, et al. Among authors: kezuka t. Ophthalmology. 2023 Apr;130(4):443-445. doi: 10.1016/j.ophtha.2022.12.020. Epub 2022 Dec 23. Ophthalmology. 2023. PMID: 36572255 No abstract available.
Intravenous immunoglobulin treatment for steroid-resistant optic neuritis: a multicenter, double-blind, randomized, controlled phase III study.
Mimura O, Ishikawa H, Kezuka T, Shikishima K, Suzuki T, Nakamura M, Chuman H, Inoue K, Kimura A, Yamagami A, Mihoya M, Nakao Y. Mimura O, et al. Among authors: kezuka t. Jpn J Ophthalmol. 2021 Jan;65(1):122-132. doi: 10.1007/s10384-020-00790-9. Epub 2021 Jan 20. Jpn J Ophthalmol. 2021. PMID: 33469728 Clinical Trial.
Correction to: Characteristics of Japanese patients with Leber's hereditary optic neuropathy and idebenone trial: a prospective, interventional, non-comparative study.
Ishikawa H, Masuda Y, Ishikawa H, Shikishima K, Goseki T, Kezuka T, Terao M, Miyazaki A, Matsumoto K, Nishikawa H, Gomi F, Mimura O. Ishikawa H, et al. Among authors: kezuka t. Jpn J Ophthalmol. 2021 Jan;65(1):143. doi: 10.1007/s10384-020-00792-7. Jpn J Ophthalmol. 2021. PMID: 33403506 No abstract available.
Characteristics of Japanese patients with Leber's hereditary optic neuropathy and idebenone trial: a prospective, interventional, non-comparative study.
Ishikawa H, Masuda Y, Ishikawa H, Shikisima K, Goseki T, Kezuka T, Terao M, Miyazaki A, Matsumoto K, Nishikawa H, Gomi F, Mimura O. Ishikawa H, et al. Among authors: kezuka t. Jpn J Ophthalmol. 2021 Jan;65(1):133-142. doi: 10.1007/s10384-020-00789-2. Epub 2020 Nov 13. Jpn J Ophthalmol. 2021. PMID: 33185792
Clinical Characteristics, Management, and Factors Associated with Poor Visual Prognosis of Acute Retinal Necrosis.
Takase H, Goto H, Namba K, Mizuki N, Okada AA, Ohguro N, Sonoda KH, Tomita M, Keino H, Kezuka T, Kubono R, Mizuuchi K, Shibuya E, Takahashi H, Yanai R, Mochizuki M; Japan ARN Study Group. Takase H, et al. Among authors: kezuka t. Ocul Immunol Inflamm. 2022 Jan 2;30(1):48-53. doi: 10.1080/09273948.2020.1789179. Epub 2020 Sep 18. Ocul Immunol Inflamm. 2022. PMID: 32945715
Changes in Etiology of Uveitis in a Single Center in Japan.
Kunimi K, Usui Y, Tsubota K, Mitsuhashi R, Umazume A, Kezuka T, Sakai J, Goto H. Kunimi K, et al. Among authors: kezuka t. Ocul Immunol Inflamm. 2021 Jul 4;29(5):976-981. doi: 10.1080/09273948.2019.1709649. Epub 2020 Feb 18. Ocul Immunol Inflamm. 2021. PMID: 32068467
101 results